"The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals general oral solid formulation facility located at Panelav from 9-13 March, 2020," the drug firm said in a filing to the BSE. This was a scheduled inspection, and at the end of the inspection, the USFDA issued a Form 483 with four procedural observations.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2wei1F1
via IFTTT
No comments:
Post a Comment